Mitsui Chemicals, Inc.
Stock Price Chart
2026/08/21 UpdatedPrice Trend
2026/08/21 UpdatedPrice & Trading Details
2026/08/21 UpdatedPRICE
TRADING
Analyst Recommendations 11 analysts
Updated 2026/08/01Earnings Calendar
Updated 2026/08/01Recent Earnings
| Date | EPS Est. | EPS Actual | Surprise |
|---|---|---|---|
| 2026/05/13 | ¥59.41 | ¥31.55 | -46.9% |
| 2026/02/04 | ¥49.62 | ¥18.31 | -63.1% |
| 2025/11/10 | ¥40.59 | ¥18.93 | -53.4% |
| 2025/08/06 | ¥27.49 | ¥1.95 | -92.9% |
Shareholder Composition
Updated 2026/08/01Dividend History
Updated 2026/08/16| Year | Dividend | Change |
|---|---|---|
| 2026 | ¥38 | -50.0% |
| 2025 | ¥75 | +3.4% |
| 2024 | ¥73 | +11.5% |
| 2023 | ¥65 | +4.0% |
| 2022 | ¥63 | - |
Financial Performance
2026/08/16 UpdatedRevenue & Profit
Margins
Cash Flow
Financial Health
| 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|
| Income Statement | ||||
| Revenue | ¥1,612,688M | ¥1,879,547M | ¥1,749,743M | ¥1,809,164M |
| Gross Profit | ¥378,740M | ¥381,493M | ¥370,797M | ¥388,292M |
| Operating Income | ¥121,491M | ¥107,305M | ¥61,822M | ¥65,907M |
| Pretax Income | ¥153,485M | ¥134,676M | ¥87,994M | ¥86,349M |
| Net Income | ¥109,990M | ¥82,936M | ¥49,999M | ¥32,242M |
| EPS | ¥282.73 | ¥215.59 | ¥131.50 | ¥85.28 |
| Operating Margin | 7.53% | 5.71% | 3.53% | 3.64% |
| Balance Sheet | ||||
| Total Assets | ¥1,934,965M | ¥2,068,203M | ¥2,215,819M | ¥2,153,953M |
| Total Equity | ¥712,654M | ¥786,827M | ¥862,851M | ¥848,284M |
| Total Liabilities | ¥1,222,311M | ¥1,281,376M | ¥1,352,968M | ¥1,305,669M |
| Cash | ¥181,152M | ¥186,310M | ¥210,292M | ¥170,615M |
| Interest-bearing Debt | ¥666,086M | ¥738,249M | ¥756,758M | ¥737,977M |
| Equity Ratio | 36.83% | 38.04% | 38.94% | 39.38% |
| D/E Ratio | 0.93 | 0.94 | 0.88 | 0.87 |
| Cash Flow | ||||
| Operating CF | ¥92,584M | ¥101,241M | ¥161,339M | ¥200,501M |
| Investing CF | -¥205,234M | -¥106,340M | -¥123,939M | -¥165,012M |
| Financing CF | ¥89,222M | ¥2,542M | -¥26,016M | -¥74,437M |
| Free CF | -¥23,632M | -¥36,620M | ¥7,348M | ¥62,095M |
| Efficiency | ||||
| ROE | 15.43% | 10.54% | 5.79% | 3.80% |
| ROA | 5.68% | 4.01% | 2.26% | 1.50% |
Latest IR Information
-
Notice Regarding Transfer of a Specified Subsidiary
In line with Ultradent acquisition, Ultradent becomes a specified subsidiary. Through in-kind contribution, the ownership ratio exceeds 10% of capital, resulting in specified subsidiary status. The anticipated impact on future performance is minor, and disclosure will be made if additional...
Read more -
Notice regarding the completion of acquisition procedures for Ultron USA
The acquisition of Ultradent in the United States has been completed. Approvals and filings with competition authorities and investment regulators were completed earlier than expected, and the company announced a plan to transfer the global headquarters function for the oral...
Read more -
First Quarter of the Fiscal Year Ending March 2027 IFRS Consolidated Financial Results (Unaudited) [IFRS] (Consolidated)
The consolidated results for the first quarter of the fiscal year ending March 2027 show net sales of 4,600,046 million yen (YoY +10.8%), core operating income of 501 million yen (YoY +88.4%), operating income of 484 million yen (YoY +279.8%),...
Read more -
Overview of the FY2026 Q1 Results and the First Half Outlook
Explains the key points of the FY2026 Q1 results, focusing on the growth of core operating profit and the trend in consolidated net sales. The Q1 sales, core operating profit, contributions from growth areas, and inventory valuation gains are presented,...
Read more -
【Mitsui Chemicals】Share Buyback Completion|July 2026
Mitsui Chemicals repurchased 50,400 shares of treasury stock on July 23, 2026, raising approximately 108,622,800 yen. The shares were allocated to directors and executive officers as part of an equity compensation program.
Read more
Latest News (5 items)
-
Average Analyst Rating: buy
Average Target Price: ¥2,363
Rating Score: 2.50 (Based on 11 analysts)
※1=Strong Buy, 5=Strong Sell
Company Information
About
Mitsui Chemicals, Inc. manufacture and sell goods or services in life & healthcare solutions, mobility solutions, ICT solutions, and basic & green materials worldwide. The company offers vision care materials, nonwoven fabrics and personal care materials, agrochemicals, and oral care materials; and elastomers, performance and polypropylene compounds, and other materials. It also provides semiconductor solutions, such as electronic component processing materials, optical materials, and lithium-ion battery materials; food packaging materials; imaging solutions, such as lens materials, materials for reflective films, and LCD and OLED sealing materials; battery material solutions; and converting solutions, including heat sealants, barrier coating materials, and packaging adhesives. In addition, the company offers petrochemicals, which comprise ethylene, propylene, high- and low-density polyethylene; basic chemicals, such as phenol, bisphenol, acetone, isopropyl alcohol, methyl isobutyl ketone, purified terephthalic acid, PET resin, ethylene oxide and glycol, hydroquinone, meta/para-cresol, ammonia, urea, and melamine; and polyurethane raw materials. Further, it provides life care solutions, such as ophthalmic lens materials, photochromic lens materials, coating materials, nonwovens, shape holding, breathable films, filtration devise, acrylamide, methacrylamide, and synthetic pulp; agrochemical products, including insecticides, fungicides, herbicides, non-crop specialty chemicals, pet medication ingredients; and medical solutions, restoratives, adhesives, artificial teeth, denture materials, impression, digital equipment/materials, medical materials, genetic testing, and contract genetic analysis services. It sells its products in Japan, China, Asia, the Americas, Europe, and internationally. Mitsui Chemicals, Inc. was founded in 1892 and is headquartered in Tokyo, Japan.